Shows
GN in TenEpisode 8: NephMadness 2025 Genetics RegionIn this special NephMadness 2025 episode, Koyal and Kenar do a deep dive into the Genetics region with NephMadness executive team member Elena Cervantes (Johns Hopkins), genetics expert Jordan Nestor (Columbia) and region writer Matt Gross (Johns Hopkins). Genetics in FSGS faces off vs. Genetic Counseling! What’s new in our ever-expanding knowledge of FSGS genetics? Where does APOL1 fit in? How should we be counseling patients before and after genetic testing, and are we actually getting the training we need to do so? And the big question: Which topic will change practice the most in the next five years? Tu...2025-03-0725 minGN in TenBoard Review Bonus #2: Minimal Change DiseaseIn this special bonus episode of the podcast, Koyal and Kenar provide a maximally useful review of minimal change disease, from diagnosis (including secondary causes to screen for) to treatment options, including how to decide which patients may do better with which therapies. Can’t get enough minimal change? Check out Episode 6 (with Astrid Weins) and Episode 7 (with Felicitas Hengel and Nicola Tomas) for more on the potential role of anti-nephrin autoantibodies in MCD.ReferencesKDIGO guidelines: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GD-Guideline-Key-Takeaways-for-Clinicians-Minimal-Change-Disease.pdfAnt...2024-09-1624 min
GN in TenBoard Review Bonus #1: IgA NephropathySHOW NOTES In this episode, Koyal and Kenar recap everything you need to know about IgAN for the board exam (or just to refresh yourself on the current state of knowledge) — from pathophysiology to treatment decisions. They also discover that nobody is really sure how to pronounce Peyer’s patches (hey, don’t blame us, they’re all the way over in the ileum) so make sure you read the show notes to settle that mystery and check out additional resources! Board Review Bonus #1 - IgA Nephropathy Online calc...2024-07-1527 minGN in TenEpisode 7: Felicitas Hengel and Nicola Tomas on a New Chapter in Anti-Nephrin AutoantibodiesIn this episode, we talk with Dr. Felicitas Hengel, MD and Dr. Nicola Tomas, MD (both at the University Medical Center Hamburg-Eppendorf) about their groundbreaking anti-nephrin autoantibody research that was just presented at the 2024 ERA Congress and published in the New England Journal of Medicine. Is this a game-changer for minimal change? How could this new understanding change diagnosis and treatment in the future? Are anti-nephrin autoantibodies the next PLA2R? What are the next steps for follow-up studies? And how do you do a big international study like this, anyway? References:The s...2024-06-0616 min
Freely Filtered, a NephJC PodcastFF 70: The PRAECIS trial, predicting severe preeclampsiaThe Filtrate:Joel TopfSwapnil HiremathAC GomezNayan AroraWith Special Guest:Anuja Java, complement god and pre-eclampsia research (Twitter)Shannon M. Clark, MD, FACOG, an honest to god, true, maternal-fetal medicine specialist. (Website | Instagram)Editor Nayan AroraShow NotesCHIP Study from 2015 (NEJM | NephMadness 2015) CHAP study from 2022 (NEJM | NephJC)NephMadness 2024 coverage of the diagnosis of preeclampsia sFlt background: Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta (PubMed)2024-05-261h 16GN in TenEpisode 6: Astrid Weins on Anti-Nephrin Antibodies and NephropathologyIn this episode, Kenar and Koyal interview Dr. Astrid Weins, MD, PhD, about nephropathology, new approaches to solving the mysteries of nephrotic syndrome, and her research on anti-nephrin antibodies in minimal change disease. Dr. Weins is Chief of Integrated Renal Pathology at Mass General/Brigham and an Assistant Professor of Pathology at Harvard.Interested in this topic? Stay tuned for additional new research on anti-nephrin antibodies that will be presented in a Late-Breaking Clinical Trials session on May 25 at the 2024 ERA Congress.References:2024-05-1717 minGN in TenEpisode 5: Industry Perspective with Jula Inrig: Endothelin Antagonism, IgAN, FSGS, Clinical Trial Career Paths, and the New Era of Nephrology TrialsIn this episode, Kenar and Koyal talk with Dr. Jula Inrig about endothelin physiology and different approaches to endothelin antagonism, trials of sparsentan in IgAN and FSGS, the art and science of clinical trial design, career paths in clinical research outside academia, and how we got to our current era of plentiful nephrology clinical trials.Disclosure: Jula Inrig is the Chief Medical Officer of Travere Therapeutics, which is one of multiple corporate partners that provide financial support to ISGD. Dr. Inrig also serves independently on the ISGD Steering Committee as a representative of industry...2024-04-2624 minGN in TenEpisode 4: NephMadness Special! Anna Burgner on PreeclampsiaIt's March, and that means it's time for NephMadness! Every year, our friends at AJKDBlog pit 16 unique regions of nephrology against each other in a basketball-style tournament. Prepare for the Preeclampsia region by listening to this special episode, where Anna Burgner from Vanderbilt University joins Kenar and Koyal to discuss recent discoveries in preeclampsia (the world's most common glomerulopathy). Will the victor be Diagnosis and Treatment of Preeclampsia, or Risk Factors, Prevention, and Long-Term Sequelae in Preeclampsia? Learn more at ajkdblog.org and submit your picks at nephmadness.com by March 31!References:2024-03-0120 minGN in TenEpisode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community EngagementWe talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well!Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisiMore information on the CARE and JUSTICE studies: https...2024-01-1115 minGN in TenEpisode 2: Kidney Week Micro-InterviewsIn this episode of GN in Ten, Koyal and Kenar take the show on the road to Kidney Week to ask attendees about their favorite glomerular diseases. Listen closely for a surprise Shakespearean crossover!2023-11-2210 minGN in TenEpisode 1: Tobias Huber on ISGD and the Future of Glomerular MedicineInternational Society of Glomerular Disease President Prof. Dr. Tobias B. Huber of the University Medical Center Hamburg-Eppendorf discusses the mission of the society and his vision for the future of glomerular disease. More information on the Hamburg Center for Kidney HealthCreators & Guests
Kenar Jhaveri - Host
Koyal Jain - Host
Tobias B. Huber - Guest
Laurel Damashek - Producer
2023-09-1910 minGN in TenWelcome to GN in Ten!Welcome to GN in Ten from the International Society of Glomerular Disease! In this trailer, our hosts Dr. Kenar Jhaveri and Dr. Koyal Jain introduce themselves and the podcast.Learn more about the International Society of Glomerular Disease (ISGD) at is-gd.org. 2023-09-0202 min
ASN PodcastKidney Week 2020 Podcast: COVID-19 and the KidneysDr. Anupam Agarwal, Dr. Kenar Jhaveri, and Dr. Kathleen Liu discuss what nephrologists have learned about how COVID-19 affects the kidneys and what remains unclear.2020-10-2315 minASN PodcastAcute Kidney Injury and COVID-19David White talks to Dr. Kenar Jhaveri, associate chief of nephrology at Northwell Health and the new Editor-in-Chief of ASN Kidney News. Dr. Jhaveri discusses his recent study, which examined AKI in patients hospitalized with COVID-19.2020-06-1624 min
Freely Filtered, a NephJC PodcastNSAIDs, opioids, and CKDThe Filtrate:Joel TopfSwapnil HiremathMatt SparksAnd special guests:Joshua Waitzman, third year nephrology fellow at Beth IsraelHarold “Harv” Feldman. Editor in Chief at AJKD and national study chair of CRIC and principal investigator of the Scientific and Data Coordinating Center of the CRIC Study. https://www.dbei.med.upenn.edu/bio/harold-i-feldman-md-msceShow Notes:CRIC: Chronic Renal Insufficiency Cohort http://www.cristudy.org/NSAID Studies at NephJC:Precision: http://www.nephjc.com/news/2017/1/20/hwgr...2020-05-241h 08